(NASDAQ: FEMY) Femasys's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 30.25%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.05%.
Femasys's earnings in 2026 is -$12,285,575.On average, 5 Wall Street analysts forecast FEMY's earnings for 2026 to be -$27,464,226, with the lowest FEMY earnings forecast at -$27,905,590, and the highest FEMY earnings forecast at -$26,645,148. On average, 5 Wall Street analysts forecast FEMY's earnings for 2027 to be -$18,152,871, with the lowest FEMY earnings forecast at -$21,257,494, and the highest FEMY earnings forecast at -$14,597,672.
In 2028, FEMY is forecast to generate -$13,454,481 in earnings, with the lowest earnings forecast at -$14,445,247 and the highest earnings forecast at -$12,223,352.